Ledger.Open graph →
SEC Form D · filed December 18, 2017

Beta Cat Pharmaceuticals, Inc

Offering
$1.4M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Houston, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Jonathan Northrup · Houston, TXExec · DirectorScott Jordan · Houston, TXExec · DirectorJoseph Cunningham · Houston, TXDirectorSunil Sharma · Houston, TXExec · DirectorKenneth Carter · Germantown, MDDirectorKenneth Carter · Gaithersburg, MDDirectorJonathan Northrup · Houston, TXExec · DirectorScott Jordan · Houston, TXExec · DirectorJoseph Cunningham · Atlanta, GADirectorSunil Sharma · Salt Lake City, UTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗